Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: Comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 1, 2003, Pages 8-12

  Paldanius, Mika ^a   Bloigu, Aini ^a   Leinonen, Maija ^a   Saikku, Pekka ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACCURACY; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CHLAMYDOPHILA PNEUMONIAE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; ENZYME IMMUNOASSAY; HUMAN; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; RELIABILITY; SEROCONVERSION; SERODIAGNOSIS;

ADULT; ANTIBODIES, BACTERIAL; CHILD; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FLUORESCEIN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 0037245990     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.1.8-12.2003     Document Type: Article

References (31)

1. Bennedsen, M., L. Berthelsen, and I. Lind. 2002. Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies. Clin. Diagn. Lab. Immunol. 9:833-839.
2. Birkebaek, N. H., J. S. Jensen, T. Seefeldt, J. Degn, B. Huniche, P. L. Andersen, and L. Ostergaard. 2000. Chlamydia pneumoniae infection in adults with chronic cough compared with healthy blood donors. Eur. Respir. J. 16:108-111.
3. Danesh, J., P. Whincup, S. Lewington, M. Walker, L. Lennon, A. Thomson, Y. K. Wong, X. Zhou, and M. Ward. 2002. Chlamydia pneumoniae IgA titres and coronary, heart disease. Prospective study and meta-analysis. Eur. Heart J. 23:371-375.
4. Dowell, S. F., R. W. Peeling, J. Boman, G. M. Carlone, B. S. Fields, J. Guarner, M. R. Hammerschlag, L. A. Jackson, C. C. Kuo, M. Maass, T. O. Messmer, D. F. Talkington, M. L. Tondella, S. R. Zaki, and C. pneumoniae Workshop Participants. 2001. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis. 33:492-503.
5. Ekman, M. R., M. Leinonen, H. Syrjala, E. Linnanmaki, P. Kujala, and P. Saikku. 1993. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur. J. Clin. Microbiol. Infect. Dis. 12:756-760.
6. Gnarpe, J., A. Sparr, J. Naas, and A. Lundback. 2000. Serological analysis of specific IgA to Chlamydia pneumoniae: increased sensitivity of IgA antibody detection using prolonged incubation and high antigen concentration. APMIS 108:357-362.
7. Grayston, J. T. 2000. What is needed to prove that Chlamydia pneumoniae does, or does not, play an etiologic role in atherosclerosis? J. Infect. Dis. 181(Suppl. 3):S585-S586.
8. Jackson, L. A., S. P. Wang, V. Nazar-Stewart, J. T. Grayston, and T. L. Vaughan. 2000. Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer Epidemiol. Biomark. Prev. 9:1263-1266.
9. Jauhiainen, T., T. Tuomi, M. Leinonen, J. D. Kark, and P. Saikku. 1994. Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations of Chlamydia pneumoniae by microimmunofluorescence test. J. Clin. Microbiol. 32:839-840.
10. Juchau, S. V., W. D. Linscott, J. Schachter, and E. Jawetz. 1972. Inhibition of antichlamydial IgM antibody by IgG antibody in immunofluorescence tests. J. Immunol. 108:1563-1569.
11. Kuo, C. C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
12. Kutlin, A., N. Tsumura, U. Emre, P. M. Roblin, and M. R. Hammerschlag. 1997. Evaluation of Chlamydia Immunoglobulin M (IgM), IgG, and lgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection. Clin. Diagn. Lab. Immunol. 4:213-216.
13. Laitinen, K., A. L. Laurila, M. Leinonen, and P. Saikku. 1996. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect. Immun. 64:1488-1490.
14. Laurila, A. L., T. Anttila, E. Laara, A. Bloigu, J. Virtamo, D. Albanes, M. Leinonen, and P. Saikku. 1997. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int. J. Cancer 74:31-34.
15. Lucey, D. R., M. Clerici, and G. M. Shearer. 1996. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9:532-562.
16. Malinverni, R., C. C. Kuo, L. A. Campbell, and J. T. Grayston. 1995. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J. Infect. Dis. 172:593-594.
17. Mestecky, J., and J. R. McGhee. 1987. Immunoglobuiin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153-245.
18. Naghavi, M., Z. Barlas, S. Siadaty, S. Naguib, M. Madjid, and W. Casscells. 2000. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 102:3039-3045.
19. Peeling, R. W., S. P. Wang, J. T. Grayston, F. Blasi, J. Boman, A. Clad, H. Freidank, C. A. Gaydos, J. Gnarpe, T. Hagiwara, R. B. Jones, J. Orfila, K. Persson, M. Puolakkainen, P. Saikku, and J. Schachter. 2000. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J. Infect. Dis. 181(Suppl. 3):S426-S429.
20. Persson, K., and J. Boman. 2000. Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin. Diagn. Lab. Immunol. 7:739-744.
21. Saikku, P., M. Leinonen, L. Tenkanen, E. Linnanmaki, M. R. Ekman, V. Manninen, M. Manttari, M. H. Frick, and J. K. Huttunen. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Intern. Med. 116:273-278.
22. Schumacher, A., A. B. Lerkerod, I. Seljeflot, L. Sommervoll, I. Holme, J. E. Otterstad, and H. Arnesen. 2001. Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J. Clin. Microbiol. 39:1859-1864.
23. Tavendale, R., D. Parratt, S. D. Pringle, R. A'brook, H. Tunstall-Pedoe, et al. 2002. Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events. Eur. Heart J. 23:301-307.
24. Tiran, A., R. A. Tio, J. M. Ossewaarde, B. Tiran, P. den Heijer, T. H. The, and M. M. Wilders-Truschnig. 1999. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies. J. Clin. Microbiol. 37:1013-1017.
25. Toss, H., J. Gnarpe, H. Gnarpe, A. Siegbahn, B. Lindahl, and L. Wallentin. 1998. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur. Heart J. 19:570-577.
26. Tuuminen, T., S. Varjo, H. Ingman, T. Weber, J. Oksi, and M. Viljanen. 2000. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays. Clin. Diagn. Lab. Immunol. 7:734-738.
27. Verkooyen, R. P., M. A. Hazenberg, G. H. Van Haaren, J. M. Van Den Bosch, R. J. Snijder, H. P. Van Helden, and H. A. Verbrugh. 1992. Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor. J. Clin. Microbiol. 30:1287-1290.
28. Wald, N. J., M. R. Law, J. K. Morris, X. Zhou, Y. Wong, and M. E. Ward. 2000. Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study. Br. Med. J. 321:204-207.
29. Wang, S. P. 2000. The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation. J. Infect. Dis. 181(Suppl. 3): S421-S425.
30. Wang, S. P., and J. T. Grayston. 1970. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am. J. Ophthalmol. 70:367-374.
31. Wu, L., S. J. Skinner, N. Lambie, J. C. Vuletic, F. Blasi, and P. N. Black. 2000. Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162:1148-1151.